Truist Securities Maintains Hold on Medtronic, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter maintains a Hold rating on Medtronic (NYSE:MDT) and lowers the price target from $88 to $85.
July 16, 2024 | 1:52 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Truist Securities has maintained its Hold rating on Medtronic and lowered the price target from $88 to $85, indicating a cautious outlook.
The Hold rating suggests that the analyst does not see significant upside potential in the short term. The lowered price target indicates a slightly more conservative outlook on the stock's performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100